Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
C Missailidis, J Hällqvist, AR Qureshi, P Barany… - PloS one, 2016 - journals.plos.org
Background The microbial metabolite Trimethylamine-N-oxide (TMAO) has been linked to
adverse cardiovascular outcome and mortality in the general population. Objective To …
adverse cardiovascular outcome and mortality in the general population. Objective To …
Associations of trimethylamine N-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis
GA Kaysen, KL Johansen, GM Chertow… - Journal of Renal …, 2015 - Elsevier
Objectives Trimethylamine N-oxide (TMAO) is a product of metabolism of
phosphatidylcholine (lecithin) and carnitine by the intestinal microbiome. Elevated serum …
phosphatidylcholine (lecithin) and carnitine by the intestinal microbiome. Elevated serum …
Elevation of trimethylamine-N-oxide in chronic kidney disease: contribution of decreased glomerular filtration rate
CC Pelletier, M Croyal, L Ene, A Aguesse… - Toxins, 2019 - mdpi.com
Gut microbiota-dependent Trimethylamine-N-oxide (TMAO) has been reported to be strongly
linked to renal function and to increased cardiovascular events in the general population …
linked to renal function and to increased cardiovascular events in the general population …
TMAO is associated with mortality: impact of modestly impaired renal function
EG Gruppen, E Garcia, MA Connelly, EJ Jeyarajah… - Scientific reports, 2017 - nature.com
Abstract Trimethylamine-N-Oxide (TMAO) is a microbiome-related metabolite that is cleared
by the kidney and linked to renal function. We explored the relationship between TMAO and …
by the kidney and linked to renal function. We explored the relationship between TMAO and …
Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden
JR Stubbs, JA House, AJ Ocque, S Zhang… - Journal of the …, 2016 - journals.lww.com
Abstract Trimethlyamine-N-oxide (TMAO) was recently identified as a promoter of
atherosclerosis. Patients with CKD exhibit accelerated development of atherosclerosis; …
atherosclerosis. Patients with CKD exhibit accelerated development of atherosclerosis; …
Trimethylamine N-oxide and risk of cardiovascular disease and mortality
Abstract Purpose of Review Trimethylamine N-oxide (TMAO) is a gut microbiota-dependent
metabolite produced from choline and phosphatidylcholine. Trimethylamine N-oxide was …
metabolite produced from choline and phosphatidylcholine. Trimethylamine N-oxide was …
[HTML][HTML] The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease
JAP Tomlinson, DC Wheeler - Kidney international, 2017 - Elsevier
Patients with chronic kidney disease (CKD) have an enhanced risk of cardiovascular (CV)
morbidity and mortality when compared with age-and gender-matched individuals with …
morbidity and mortality when compared with age-and gender-matched individuals with …
Trimethylamine N-oxide and cardiovascular outcomes in patients with ESKD receiving maintenance hemodialysis
Results We observed a wide distribution of serum TMAO in our cohort, with approximately
80% of participants exhibiting TMAO concentrations≥ 56 µM and a maximum TMAO …
80% of participants exhibiting TMAO concentrations≥ 56 µM and a maximum TMAO …
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney …
Rationale: Trimethylamine-N-oxide (TMAO), a gut microbial-dependent metabolite of dietary
choline, phosphatidylcholine (lecithin), and l-carnitine, is elevated in chronic kidney …
choline, phosphatidylcholine (lecithin), and l-carnitine, is elevated in chronic kidney …
[HTML][HTML] Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events
RB Kim, BL Morse, O Djurdjev, M Tang, N Muirhead… - Kidney international, 2016 - Elsevier
Cardiovascular disease is more common in patients with chronic kidney disease (CKD), and
traditional risk factors do not adequately predict those at risk for cardiovascular (CV) events …
traditional risk factors do not adequately predict those at risk for cardiovascular (CV) events …
相关搜索
- kidney disease trimethylamine n oxide
- cardiovascular outcomes trimethylamine n oxide
- kidney disease renal function
- filtration rate trimethylamine n oxide
- kidney disease mortality risk
- kidney disease filtration rate
- kidney disease cardiovascular complications
- kidney disease human plasma
- human plasma trimethylamine n oxide
- kidney function meta analysis
- decreased production trimethylamine n oxide
- metabolomics analysis trimethylamine n oxide
- maintenance hemodialysis trimethylamine n oxide
- kidney disease decreased production
- kidney disease metabolomics analysis
- kidney disease renal insufficiency